Bausch & Lomb/Immunetech Pharmaceuticals
Executive Summary
Bausch & Lomb has obtained an exclusive U.S. and Canadian iicence for the ophthalmic indications of Immunetech's new Rx anti-allergy drug. Bausch & Lomb said the drug, which wili be included in eye drop solutions, will be used in the treatment of allergic, vernal and giant papiliary conjunctivitis . . . .